Veradigm EBITDA Margin 2012-2022 | MDRX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Veradigm (MDRX) over the last 10 years. The current EBITDA margin for Veradigm as of December 31, 2022 is .
| Veradigm EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2022-12-31 | $0.59B | $0.08B | 13.41% |
| 2022-09-30 | $0.60B | $0.13B | 20.86% |
| 2022-06-30 | $0.60B | $0.12B | 20.44% |
| 2022-03-31 | $0.59B | $0.15B | 25.04% |
| 2021-12-31 | $0.58B | $0.15B | 25.95% |
| 2021-09-30 | $-0.14B | $0.11B | -75.00% |
| 2021-06-30 | $0.08B | $0.11B | 130.86% |
| 2021-03-31 | $0.31B | $0.09B | 29.77% |
| 2020-12-31 | $0.56B | $0.10B | 17.27% |
| 2020-09-30 | $1.43B | $0.00B | 0.21% |
| 2020-06-30 | $1.51B | $0.03B | 1.86% |
| 2020-03-31 | $1.58B | $0.07B | 4.36% |
| 2019-12-31 | $1.63B | $0.10B | 6.07% |
| 2019-09-30 | $1.63B | $0.13B | 8.16% |
| 2019-06-30 | $1.62B | $0.12B | 7.42% |
| 2019-03-31 | $1.62B | $0.05B | 2.85% |
| 2018-12-31 | $1.62B | $0.03B | 1.79% |
| 2018-09-30 | $1.52B | $0.03B | 2.18% |
| 2018-06-30 | $1.53B | $0.06B | 4.17% |
| 2018-03-31 | $1.52B | $0.15B | 9.88% |
| 2017-12-31 | $1.50B | $0.17B | 11.36% |
| 2017-09-30 | $1.55B | $0.25B | 16.06% |
| 2017-06-30 | $1.49B | $0.23B | 15.47% |
| 2017-03-31 | $1.45B | $0.22B | 15.06% |
| 2016-12-31 | $1.39B | $0.20B | 14.71% |
| 2016-09-30 | $1.47B | $0.23B | 15.50% |
| 2016-06-30 | $1.43B | $0.22B | 15.14% |
| 2016-03-31 | $1.40B | $0.20B | 14.52% |
| 2015-12-31 | $1.39B | $0.19B | 13.91% |
| 2015-09-30 | $1.38B | $0.18B | 12.74% |
| 2015-06-30 | $1.37B | $0.15B | 10.92% |
| 2015-03-31 | $1.37B | $0.14B | 10.06% |
| 2014-12-31 | $1.38B | $0.14B | 9.80% |
| 2014-09-30 | $1.39B | $0.11B | 8.00% |
| 2014-06-30 | $1.37B | $0.09B | 6.56% |
| 2014-03-31 | $1.37B | $0.07B | 5.12% |
| 2013-12-31 | $1.37B | $0.05B | 3.71% |
| 2013-09-30 | $1.37B | $0.05B | 3.28% |
| 2013-06-30 | $1.40B | $0.09B | 6.34% |
| 2013-03-31 | $1.43B | $0.13B | 9.03% |
| 2012-12-31 | $1.45B | $0.16B | 11.26% |
| 2012-09-30 | $1.48B | $0.23B | 15.57% |
| 2012-06-30 | $1.49B | $0.25B | 16.95% |
| 2012-03-31 | $1.47B | $0.26B | 17.77% |
| 2011-12-31 | $1.44B | $0.27B | 18.63% |
| 2011-09-30 | $1.37B | $0.20B | 14.36% |
| 2011-06-30 | $1.25B | $0.15B | 11.60% |
| 2011-03-31 | $1.08B | $0.11B | 10.15% |
| 2010-09-30 | $0.62B | $0.09B | 14.10% |
| 2010-06-30 | $0.56B | $0.11B | 20.18% |
| 2010-03-31 | $0.53B | $0.12B | 23.08% |
| 2010-02-28 | $0.51B | $0.10B | 20.23% |
| 2009-09-30 | $0.49B | $0.08B | 16.50% |
| 2009-08-31 | $0.46B | $0.06B | 12.31% |
| 2009-02-28 | $0.47B | $0.02B | 4.52% |
| 2008-11-30 | $0.39B | $0.00B | -0.78% |
| 2008-08-31 | $0.25B | $0.02B | 6.48% |
| 2008-06-30 | $0.25B | $0.04B | 17.13% |
| 2008-03-31 | $0.34B | $0.09B | 25.15% |
| 2008-02-29 | $0.34B | $0.09B | 27.06% |
| 2007-12-31 | $0.31B | $0.08B | 25.88% |
| 2007-11-30 | $0.41B | $0.06B | 14.36% |
| 2007-09-30 | $0.38B | $0.06B | 15.26% |
| 2007-06-30 | $0.37B | $0.06B | 15.24% |
| 2007-05-31 | $0.37B | $0.06B | 15.03% |
| 2007-03-31 | $0.25B | $0.04B | 17.53% |
| 2006-12-31 | $0.23B | $0.04B | 16.23% |
| 2006-09-30 | $0.20B | $0.03B | 15.15% |
| 2006-06-30 | $0.17B | $0.02B | 14.37% |
| 2006-03-31 | $0.14B | $0.02B | 13.14% |
| 2005-12-31 | $0.12B | $0.02B | 13.22% |
| 2005-09-30 | $0.11B | $0.01B | 12.39% |
| 2005-06-30 | $0.11B | $0.01B | 11.11% |
| 2005-03-31 | $0.10B | $0.01B | 9.62% |
| 2004-12-31 | $0.10B | $0.01B | 7.92% |
| 2004-09-30 | $0.10B | $0.01B | 6.06% |
| 2004-06-30 | $0.10B | $0.00B | 4.21% |
| 2004-03-31 | $0.09B | $0.00B | 1.12% |
| 2003-12-31 | $0.09B | $0.00B | -1.16% |
| 2003-09-30 | $0.08B | $0.00B | -3.66% |
| 2003-06-30 | $0.08B | $-0.01B | -7.50% |
| 2003-03-31 | $0.08B | $-0.01B | -10.00% |
| 2002-12-31 | $0.08B | $-0.01B | -15.19% |
| 2002-09-30 | $0.08B | $-0.02B | -23.08% |
| 2002-06-30 | $0.07B | $-0.39B | -527.03% |
| 2002-03-31 | $0.07B | $-0.40B | -542.47% |
| 2001-12-31 | $0.07B | $-0.40B | -569.01% |
| 2001-09-30 | $0.07B | $-0.40B | -574.29% |
| 2001-06-30 | $0.07B | $-0.03B | -49.28% |
| 2001-03-31 | $0.06B | $-0.05B | -74.19% |
| 2000-12-31 | $0.06B | $-0.04B | -70.91% |
| 2000-09-30 | $0.05B | $-0.04B | -86.67% |
| 2000-06-30 | $0.04B | $-0.04B | -97.30% |
| 2000-03-31 | $0.03B | $-0.02B | -58.06% |
| 1999-12-31 | $0.03B | $-0.01B | -51.85% |
| 1999-06-30 | $0.02B | $0.00B | 5.56% |
| 1999-03-31 | $0.02B | $0.01B | 55.56% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.587B | $0.594B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $42.703B | 42.61 |
| Tempus AI (TEM) | United States | $14.500B | 0.00 |
| 10x Genomics (TXG) | United States | $10.029B | 0.00 |
| Hinge Health (HNGE) | United States | $7.643B | 73.43 |
| Hims & Hers Health (HIMS) | United States | $6.507B | 0.00 |
| Doximity (DOCS) | United States | $4.736B | 29.20 |
| Heartflow (HTFL) | United States | $4.310B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.684B | 242.93 |
| Privia Health (PRVA) | United States | $2.566B | 95.67 |
| Clover Health Investments (CLOV) | United States | $2.411B | 0.00 |
| Schrodinger (SDGR) | United States | $2.232B | 0.00 |
| Butterfly Network (BFLY) | United States | $2.120B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.103B | 32.04 |
| Omnicell (OMCL) | United States | $1.484B | 21.18 |
| Azenta (AZTA) | United States | $1.473B | 80.07 |
| Enovis (ENOV) | United States | $1.027B | 5.31 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.716B | 0.00 |
| Phreesia (PHR) | United States | $0.638B | 34.27 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Claritev (CTEV) | United States | $0.538B | 0.00 |
| Carlsmed (CARL) | United States | $0.420B | 0.00 |
| Evolent Health (EVH) | United States | $0.415B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.394B | 0.00 |
| CapsoVision (CV) | United States | $0.317B | 0.00 |
| Standard BioTools (LAB) | United States | $0.287B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.135B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.094B | 6.94 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Outset Medical (OM) | United States | $0.058B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.047B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.027B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| HeartSciences (HSCS) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |